FDA approves study of ATS Medical's heart valve

08/27/2009 | Forbes

The FDA has allowed ATS Medical to conduct a clinical trial to test its ATS 3f Aortic Bioprosthesis heart valve in patients younger than 60 who need to an aortic valve replacement. The device, which functions like a natural cardiac valve, was cleared by the FDA in October.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC